SECUKINUMAB PROVIDES SUSTAINED REDUCTION IN FATIGUE IN PATIENTS WITH ANKYLOSING SPONDYLITIS THROUGH 3 YEARS: LONG-TERM RESULTS OF TWO RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 STUDIES

被引：0
|
作者：
Kvien, T. K. [1 ]
Deodhar, A. [2 ]
Gossec, L. [3 ]
Conaghan, P. G. [4 ]
Strand, V. [5 ]
Ostergaard, M. [6 ]
Williams, N. [7 ]
Porter, B. [8 ]
Gandhi, K. [8 ]
Jugl, S. [9 ]
机构：
[1] Diakonhjemmet Hosp, Oslo, Norway
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[3] UPMC Univ Paris 06, Paris, France
[4] Univ Leeds, Leeds, W Yorkshire, England
[5] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[6] Copenhagen Ctr Arthrit Res COPECARE, Glostrup, Denmark
[7] RTI Hlth Solut, Durham, NC USA
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Novartis Pharma AG, Basel, Switzerland
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
363
引用
收藏
页码：S9 / S9
页数：1
相关论文
共 50 条
  • [31] Milnacipran improves fatigue in patients with fibromyalgia: Results from two randomized, double-blind, placebo-controlled trials
    Clauw, Daniel J.
    Palmer, Robert H.
    Hufford, Michael R.
    Zablocki, Rung
    Wang, Yong
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S383 - S383
  • [32] Sulphasalazine in ankylosing spondylitis: a prospective, randomized, double-blind, placebo-controlled study and meta-analysis of other controlled studies
    Schmidt, WA
    Wierth, S
    Milleck, D
    Droste, U
    Gromnica-Ihle, E
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2002, 61 (02): : 159 - +
  • [33] Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
    Hayden, Frederick G.
    Lenk, Robert P.
    Stonis, Lucille
    Oldham-Creamer, Catherine
    Kang, Lih Lisa
    Epstein, Carol
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (10): : 1790 - 1799
  • [34] INTRAVENOUS LOADING AND SUBCUTANEOUS MAINTENANCE WITH SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT IN MULTIPLE MEASURES OF DISEASE ACTIVITY IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 52-WEEK DATA FROM THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 MEASURE 1 STUDY
    Wei, J. C. C.
    Baeten, D. L.
    Geusens, P.
    Porter, B.
    Martin, R.
    Richards, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1146 - 1147
  • [35] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES
    Schett, Georg
    Baraliakos, Xenofon
    van den Bosch, Filip
    Deodhar, Atul
    Gensler, Lianne S.
    Ostergaard, Mikkel
    Agawane, Shital
    Das Gupta, Ayan
    Mpofu, Shephard
    Fox, Todd
    Winseck, Adam
    Shete, Abhijit
    Porter, Brian
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 873 - 874
  • [36] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES
    Barkham, Nick
    Schett, Georg
    Baraliakos, Xenofon
    van den Bosch, Filip
    Deodhar, Atul
    Gensler, Lianne S.
    Ostergaard, Mikkel
    Agawane, Shital
    Gupta, Ayan Das
    Mpofu, Shephard
    Fox, Todd
    Winseck, Adam
    Shete, Abhijit
    Porter, Brian
    RHEUMATOLOGY, 2020, 59
  • [37] ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria
    Gema Ariceta
    Laure Collard
    Saoussen Abroug
    Shabbir H. Moochhala
    Edward Gould
    Abir Boussetta
    Mohamed Ben Hmida
    Sudarsana De
    Tracy E. Hunley
    Faical Jarraya
    Gloria Fraga
    Ana Banos
    Elisabeth Lindner
    Bastian Dehmel
    Gesa Schalk
    Pediatric Nephrology, 2023, 38 : 403 - 415
  • [38] ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria
    Ariceta, Gema
    Collard, Laure
    Abroug, Saoussen
    Moochhala, Shabbir H.
    Gould, Edward
    Boussetta, Abir
    Ben Hmida, Mohamed
    De, Sudarsana
    Hunley, Tracy E.
    Jarraya, Faical
    Fraga, Gloria
    Banos, Ana
    Lindner, Elisabeth
    Dehmel, Bastian
    Schalk, Gesa
    PEDIATRIC NEPHROLOGY, 2023, 38 (02) : 403 - 415
  • [39] Disability Severity Category Shift With Fremanezumab Treatment: Pooled Results of 3 Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
    Nagy, A. J.
    Cohen, J. M.
    Ning, X.
    Ramirez-Campos, V
    Janka, L.
    McAllister, P.
    HEADACHE, 2020, 60 : 11 - 11
  • [40] Secukinumab improves active psoriatic arthritis and inhibits radiographic progression: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled study
    Mease, P.
    McInnes, I. B.
    Kirkham, B.
    Kavanaugh, A.
    Rahman, P.
    Van Der Heijde, D.
    Landewe, R.
    Nash, P.
    Pricop, L.
    Yuan, J.
    Richards, H.
    Mpofu, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S29 - S29
12345